Use of Tachosil® for Lymph Sealing During Surgery

NCT01920958 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 233

Last updated 2016-12-19

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to describe effectiveness and reliability of TachoSil® in lymph sealing after lymphadenectomy.

Conditions

  • Lymph Node Resection

Interventions

OTHER

TachoSil®

TachoSil® is a collagen sponge that is coated with the active substances human fibrinogen and human thrombin and that supports hemostasis and tissue sealing in surgery.

Sponsors & Collaborators

Principal Investigators

  • Medical Director · Takeda Pharma Vertrieb GmbH & Co. KG

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2014-03-31
Completion
2014-03-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01920958 on ClinicalTrials.gov